Results from a systematic review and meta-analysis found that prepregnancy maternal obesity is associated with a significantly increased risk for child obesity.
This adverse effect is further aggravated by an unfavorable metabolic profile
Prebiotic supplementation may serve as an inexpensive and low-risk treatment addition to improve glycemic control in patients with type 1 diabetes.
Livalo is indicated for pediatric patients ≥8 years old with HeFH to reduce TC, LDL-C, and Apo-B.
Completion of full rotavirus vaccination appears to be associated with a reduction in the risk of type 1 diabetes in children.
The approval of Victoza in this patient population was based on data from the ELLIPSE trial which included 134 children and adolescents.
The Omnipod HCL system was safe and performed well in children aged 2 to 6 years with type 1 diabetes.
A gluten-free diet was associated with lower insulin demand and HbA1c in T1D.
Researchers reported that collaboration among medical providers, patients, and caregivers was important for optimal glycemic control in youth with type 1 diabetes.
Teasing in youth with or at risk for overweight associated with greater gain in BMI and fat mass
Incidence rates of pediatric thyroid cancer have increased in the United States, likely attributable to enhanced diagnostic practices and an increase in thyroid cancer in the pediatric population.